Your browser doesn't support javascript.
loading
Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group.
Kim, Kangsan; Narasimhan, Madhusudhanan; Mahimainathan, Lenin; Zhang, Ray; Araj, Ellen; Kim, Elizabeth; Tharpe, William; Greenberg, Benjamin M; Greenberg, David E; Li, Quan-Zhen; Cheng, Chi-An; Sarode, Ravi; Malladi, Srinivas; Muthukumar, Alagarraju.
Afiliação
  • Kim K; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Narasimhan M; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Mahimainathan L; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Zhang R; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Araj E; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Kim E; William P. Clements Jr. University Hospital, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Tharpe W; William P. Clements Jr. University Hospital, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Greenberg BM; Department of Neurology and Neurotherapeutics, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Greenberg DE; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Li QZ; Department of Microbiology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Cheng CA; Microarray Core, Department of Immunology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Sarode R; School of Pharmacy, National Taiwan University, Taipei, Taiwan.
  • Malladi S; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Muthukumar A; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
Front Immunol ; 13: 1020165, 2022.
Article em En | MEDLINE | ID: mdl-36389788
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 4_pneumonia Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 4_pneumonia Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos